Clinical Trials Directory

Trials / Completed

CompletedNCT03616119

Gastroesophageal Reflux Disease in Azerbaijan

The Prevalence of Gastroesophageal Reflux Disease in Azerbaijan

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Sevda Aghayeva · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

To evaluate the prevalence of Gastroesophageal reflux disease in Azerbaijan. It is intended to evaluate the prevalence of the disease in the regions as well as the capital by cluster sampling ,ethitology and to compare the outcomes depending on the geographical location.

Detailed description

It is an observational, nationwide study. The GERD questionnaire (1994) requested from Mayo clinic, was received and validated. The questionnaire was translated by 3 individuals from english to azeri and back trasnlated by 3 native english speakers. Power analysis was performed. The research was presented for the approval to Ethical Committee of Azerbaijan Medical University. Prior to the actual study, a pilot study with smaller number of participants was performed and the results were evaluated. Cluster sampling methodology was provided by the statistical department of Azerbaijan Medical University. 110 employees were hired for using a survey in different regions of Azerbaijan. Written consent was obtained from every person evaluated. Statistical ananlysis was performed.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2019-08-01
Completion
2019-09-01
First posted
2018-08-06
Last updated
2022-12-13

Locations

1 site across 1 country: Azerbaijan

Source: ClinicalTrials.gov record NCT03616119. Inclusion in this directory is not an endorsement.